Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-21

Clinical Trial Update: Study to Evaluate Efficacy and Safety of NDS-446 in Men With Lower Urinary Tract Symptoms (LUTS) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of NDS-446 in men with lower urinary tract symptoms (LUTS). Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NDS-446

Snippet

Sponsor: Naturex-Dbs | Conditions: Lower Urinary Tract Symptoms | Phase 2 | Status: UNKNOWN